​

Orchestra BioMed Ownership | Who Owns Orchestra BioMed?


OverviewForecastRevenueFinancialsChart

Orchestra BioMed Ownership Summary


Orchestra BioMed is owned by 43.95% institutional investors, 24.43% insiders, and 31.62% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 21.63% of OBIO shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.46% of its assets in Orchestra BioMed shares.

OBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOrchestra BioMed43.95%24.43%31.62%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp8.31M21.63%$35.30M
Perceptive advisors5.04M13.12%$21.41M
Blackrock funding, inc. /de2.72M4.25%$16.89M
Vanguard group1.60M4.18%$6.66M
Vanguard capital management2.00M3.14%$12.46M
Alyeska investment group1.00M2.60%$4.25M
Geode capital management1.00M1.57%$6.25M
Propel bio management896.70K1.41%$5.58M
Knoll capital management455.13K1.19%$421.16K
State street605.78K0.95%$3.77M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Propel bio management896.70K2.96%$5.58M
Lasry marc60.87K1.00%$150.96K
Knott david m jr253.65K0.86%$1.58M
Amh equity166.00K0.51%$411.68K
Perceptive advisors5.04M0.42%$21.41M
Rtw investments, lp8.31M0.35%$35.30M
Knoll capital management455.13K0.23%$421.16K
Holos integrated wealth51.59K0.13%$291.51K
Dafna capital management126.84K0.12%$539.07K
Meramec financial planners30.00K0.06%$170.40K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de2.72M0.00%204.66K
Ubs group525.07K0.00%199.29K
Amh equity166.00K0.51%166.00K
Vanguard group1.60M0.00%122.68K
State street605.78K0.00%89.73K

Top Sellers

HolderShares% AssetsChange
Pathstone---1.01M
Millennium management---702.54K
Price t rowe associates inc /md/---364.64K
Sixth street partners management company---349.54K
Marshall wace, llp---188.48K

New Positions

HolderShares% AssetsChangeValue
Amh equity166.00K0.51%166.00K$411.68K
Sei investments77.60K0.00%77.60K$482.67K
Empowered funds72.27K0.00%72.27K$449.52K
Jump financial21.90K0.00%21.90K$136.22K
Rice hall james & associates19.00K0.00%19.00K$80.75K

Sold Out

HolderChange
True wealth design-6.00
Gamma investing-101.00
Sierra ocean-119.00
Fortitude family office-203.00
Nisa investment advisors-241.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20268122.73%28,044,44421.43%433.24%4811.63%1515.38%
Mar 31, 202664-3.03%22,997,8025.97%591.87%4216.67%13-18.75%
Dec 31, 202511-78.85%1,738,363-92.42%40.13%7-72.00%--100.00%
Sep 30, 202510-82.76%1,953,498-89.23%50.23%4-88.57%3-81.25%
Jun 30, 2025585.45%18,134,637-4.51%471.91%3552.17%16-11.11%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor1.47M2.46%-257.90K
Vanguard Total Stock Mkt Idx Inv1.47M2.46%-257.90K
Vanguard MStar Total Stk Mkt Idx Invest1.47M2.45%-
iShares Russell 2000 ETF959.65K1.60%-
Vanguard Institutional Extnd Mkt Idx Tr498.63K0.83%-
Fidelity Small Cap Index428.76K0.71%-
iShares Russell 2000 Growth ETF378.59K0.63%-1.43K
UBS(Lux)EF Sust Hlth Trnsfm $ P362.04K0.60%17.62K
UBS (Lux) EF Biotech (USD) P-acc341.29K0.57%43.55K
Russell 2000 Index Non-Lendable Fund246.00K0.41%246.00K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 09, 2026RTW INVESTMENTS, LP-Buy$6.00M
Nov 09, 2026Fain Eric S-Buy$100.00K
Nov 09, 2026Pacitti David-Buy$100.00K
Nov 09, 2026Hochman David P See RemarksBuy$25.00K
Nov 09, 2026Taylor Andrew Lawrence Chief Financial OfficerBuy$5.00K

Insider Transactions Trends


DateBuySell
2026 Q442
2026 Q323
2026 Q252
2026 Q11-
2025 Q41-

OBIO Ownership FAQ


Who Owns Orchestra BioMed?

Orchestra BioMed shareholders are primarily institutional investors at 43.95%, followed by 24.43% insiders and 31.62% retail investors. The average institutional ownership in Orchestra BioMed's industry, Biotech Stocks , is 385.89%, which Orchestra BioMed falls below.

Who owns the most shares of Orchestra BioMed?

Orchestra BioMed’s largest shareholders are Rtw investments, lp (8.31M shares, 21.63%), Perceptive advisors (5.04M shares, 13.12%), and Blackrock funding, inc. /de (2.72M shares, 4.25%). Together, they hold 39.01% of Orchestra BioMed’s total shares outstanding.

Does Blackrock own Orchestra BioMed?

BlackRock is not among the top 10 institutional shareholders of Orchestra BioMed.

Who is Orchestra BioMed’s biggest shareholder by percentage of total assets invested?

Propel bio management is Orchestra BioMed’s biggest shareholder by percentage of total assets invested, with 2.96% of its assets in 896.7K Orchestra BioMed shares, valued at 5.58M$.

Who is the top mutual fund holder of Orchestra BioMed shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Orchestra BioMed shares, with 2.46% of its total shares outstanding invested in 1.47M Orchestra BioMed shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools